Suppr超能文献

非酒精性和酒精性肝病的多病因学:是否有理由将其区分开来?

Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?

机构信息

Institute for Community Medicine, University of Greifswald, D-17487 Greifswald, Germany.

出版信息

World J Gastroenterol. 2012 Jul 21;18(27):3492-501. doi: 10.3748/wjg.v18.i27.3492.

Abstract

Apart from alcohol, there are other factors that may induce complications, which resemble alcohol-related liver disorders. In particular, obesity has been brought into focus as a risk factor for fatty liver disease. The term "non-alcoholic" fatty liver disease is commonly used to distinguish between obesity-related and alcohol-related hepatic steatosis. This review uses the epidemiological perspective to critically assess whether it is necessary and useful to differentiate between alcoholic and "non-alcoholic" fatty liver disease. The MEDLINE database was searched using the PubMed search engine, and a review of reference lists from original research and review articles was conducted. The concept to distinguish between alcoholic and "non-alcoholic" fatty liver disease is mainly based on specific pathomechanisms. This concept has, however, several limitations including the common overlap between alcohol misuse and obesity-related metabolic disorders and the non-consideration of additional causal factors. Both entities share similar histopathological patterns. Studies demonstrating differences in clinical presentation and outcome are often biased by selection. Risk factor reduction is the main principle of prevention and treatment of both disease forms. In conclusion, alcoholic and "non-alcoholic" fatty liver diseases are one and the same disease caused by different risk factors. A shift from artificial categories to a more general approach to fatty liver disease as a multicausal disorder may optimize preventive strategies and help clinicians more effectively treat patients at the individual level.

摘要

除了酒精,还有其他可能导致类似酒精性肝病的并发症的因素。特别是肥胖已成为脂肪肝的一个危险因素而受到关注。“非酒精性”脂肪肝这个术语通常用于区分与肥胖相关和与酒精相关的肝脂肪变性。本综述使用流行病学的观点来批判性地评估是否有必要和有用来区分酒精性和“非酒精性”脂肪肝。使用 PubMed 搜索引擎检索 MEDLINE 数据库,并对原始研究和综述文章的参考文献进行综述。区分酒精性和“非酒精性”脂肪肝的概念主要基于特定的发病机制。然而,这个概念有几个局限性,包括酒精滥用和肥胖相关代谢紊乱之间的常见重叠,以及不考虑其他因果因素。这两种疾病都有相似的组织病理学模式。表现出临床表现和结局差异的研究往往存在选择偏倚。减少危险因素是预防和治疗这两种疾病形式的主要原则。总之,酒精性和“非酒精性”脂肪肝是由不同的危险因素引起的同一种疾病。从人为的分类向更普遍的方法转变,将脂肪肝视为一种多病因疾病,可能会优化预防策略,并帮助临床医生在个体层面更有效地治疗患者。

相似文献

1
Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?
World J Gastroenterol. 2012 Jul 21;18(27):3492-501. doi: 10.3748/wjg.v18.i27.3492.
2
Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.
J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:11-7. doi: 10.1111/jgh.12036.
3
[Not Available].
Ugeskr Laeger. 2024 May 6;186(19):V12230778. doi: 10.61409/V12230778.
4
Biphasic effect of alcohol intake on the development of fatty liver disease.
J Gastroenterol. 2015 Nov;50(11):1114-23. doi: 10.1007/s00535-015-1058-z. Epub 2015 Mar 3.
5
Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
Nutrients. 2018 Jan 15;10(1):89. doi: 10.3390/nu10010089.
6
Predictive factors for pure steatosis in alcoholic patients.
Alcohol Clin Exp Res. 2009 Jun;33(6):1104-10. doi: 10.1111/j.1530-0277.2009.00932.x. Epub 2009 Mar 23.
7
ASH and NASH.
Dig Dis. 2011;29(2):202-10. doi: 10.1159/000323886. Epub 2011 Jul 5.
8
Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).
Curr Pharm Des. 2020;26(10):1079-1092. doi: 10.2174/1381612826666200128094231.
9
Pathophysiological similarities and synergisms in alcoholic and non-alcoholic steatohepatitis.
Dig Dis. 2010;28(6):783-91. doi: 10.1159/000324286. Epub 2011 Apr 27.
10
The epidemiology, pathogenesis and histopathology of fatty liver disease.
Histopathology. 2012 Aug;61(2):141-52. doi: 10.1111/j.1365-2559.2011.04145.x. Epub 2012 Feb 28.

引用本文的文献

1
DOME: Directional medical embedding vectors from Electronic Health Records.
J Biomed Inform. 2025 Feb;162:104768. doi: 10.1016/j.jbi.2024.104768. Epub 2025 Jan 2.
2
MetALD: Does it require a different therapeutic option?
Hepatology. 2024 Dec 1;80(6):1424-1440. doi: 10.1097/HEP.0000000000000935. Epub 2024 May 31.
3
Pathogenesis of Alcoholic Fatty Liver a Narrative Review.
Life (Basel). 2023 Jul 30;13(8):1662. doi: 10.3390/life13081662.
4
Hematological Indices Are Useful in Predicting Complications of Liver Cirrhosis.
J Clin Med. 2023 Jul 21;12(14):4820. doi: 10.3390/jcm12144820.
7
Nonalcoholic Fatty Liver Disease Is Associated with Infection in North Urban Chinese: A Retrospective Study.
Gastroenterol Res Pract. 2020 Jan 25;2020:9797841. doi: 10.1155/2020/9797841. eCollection 2020.
9
Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis.
Biomed Res Int. 2019 Apr 4;2019:5308308. doi: 10.1155/2019/5308308. eCollection 2019.
10
Genetic and Epigenetic Modifiers of Alcoholic Liver Disease.
Int J Mol Sci. 2018 Dec 3;19(12):3857. doi: 10.3390/ijms19123857.

本文引用的文献

2
Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease.
Virchows Arch. 2011 May;458(5):511-23. doi: 10.1007/s00428-011-1066-1. Epub 2011 Mar 26.
3
Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.
Drug Metab Pharmacokinet. 2011;26(1):30-46. doi: 10.2133/dmpk.dmpk-10-rv-087. Epub 2010 Dec 7.
6
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
N Engl J Med. 2010 May 6;362(18):1675-85. doi: 10.1056/NEJMoa0907929. Epub 2010 Apr 28.
7
Role of alcohol metabolism in non-alcoholic steatohepatitis.
PLoS One. 2010 Mar 8;5(3):e9570. doi: 10.1371/journal.pone.0009570.
8
Cohort profile: the study of health in Pomerania.
Int J Epidemiol. 2011 Apr;40(2):294-307. doi: 10.1093/ije/dyp394. Epub 2010 Feb 18.
9
Werner syndrome as a possible cause of non-alcoholic steatohepatitis.
J Clin Pathol. 2009 Nov;62(11):1043-5. doi: 10.1136/jcp.2009.070680. Epub 2009 Aug 30.
10
Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample.
Eur J Endocrinol. 2009 Nov;161(5):705-13. doi: 10.1530/EJE-09-0374. Epub 2009 Aug 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验